Novavax
NVAX
173 hedge funds and large institutions have $1.71B invested in Novavax in 2015 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 66 increasing their positions, 47 reducing their positions, and 46 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 47
37% more call options, than puts
Call options by funds: $16.7M | Put options by funds: $12.2M
23% more capital invested
Capital invested by funds: $1.39B → $1.71B (+$320M)
9% less funds holding
Funds holding: 190 → 173 (-17)
33% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 46
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$63.1M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$23M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$22M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$13.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$12.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$24M |
| 2 |
Millennium Management
New York
|
-$14.1M |
| 3 |
Renaissance Technologies
New York
|
-$12.9M |
| 4 |
DM
Deerfield Management
New York
|
-$7.35M |
| 5 |
D.E. Shaw & Co
New York
|
-$6.89M |
NVAX Hedge Fund Activity: Q4 2015 in Review
173 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2015, worth a combined $1.71B — up 23% from $1.39B a quarter earlier.
Sellers outnumbered buyers: 46 funds closed out of NVAX and 31 opened new positions — a net loss of 15 holders — while 47 trimmed existing stakes and 66 added.
The largest buyer was Fidelity Investments, adding an estimated $63.1M. The largest seller was Wells Fargo, cutting an estimated $24M.
- 173 institutional investors held Novavax (NVAX) as of Q4 2015, down from 190 in Q3 2015.
- Funds reported $1.71B of Novavax stock for Q4 2015, up 23% quarter-over-quarter.
- 31 funds opened new Novavax positions in Q4 2015 and 46 closed out, a net change of -15 holders.
- The largest Novavax buyer in Q4 2015 was Fidelity Investments, an estimated $63.1M added.
- The largest Novavax seller in Q4 2015 was Wells Fargo, an estimated $24M sold.
Based on aggregated 13F filings for Q4 2015.